[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Pankewycz et al., 1992 - Google Patents

A protective NOD islet‐infiltrating CD8+ T cell clone, IS 2.15, has in vitro immunosuppressive properties

Pankewycz et al., 1992

Document ID
17738255681001845186
Author
Pankewycz O
Guan J
Benedict J
Publication year
Publication venue
European journal of immunology

External Links

Snippet

Type 1, insulin‐dependent diabetes mellitus (IDDM) appears to result from a T cell‐ dependent destruction of insulin‐producing pancreatic β cells. In non‐obese diabetic (NOD) mice and in other rodent models of human IDDM, final expression of disease may be …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes

Similar Documents

Publication Publication Date Title
Muir et al. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription.
Boissier et al. Biphasic effect of interferon‐γ in murine collagen‐induced arthritis
Weinberg OX40: targeted immunotherapy-implications for tempering autoimmunity and enhancing vaccines
Vanderlugt et al. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis
Smyth et al. Sequential production of interferon-γ by NK1. 1+ T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide
DE69737969T2 (en) DNA VACCINATION TO INTRODUCE A SUPPRESSIVE T CELL RESPONSE
Murphy et al. New strategies for preventing graft-versus-host disease
Tanaka et al. A pivotal role of IL-12 in Th1-dependent mouse liver injury
Pankewycz et al. A protective NOD islet‐infiltrating CD8+ T cell clone, IS 2.15, has in vitro immunosuppressive properties
WO2007136518A2 (en) Treatment of autoimmune disorders
JP2547162B2 (en) Methods and compositions for inhibiting allograft rejection in mammals
Pankewycz et al. Islet‐infiltrating T cell clones from non‐obese diabetic mice that promote or prevent accelerated onset diabetes
US5624938A (en) Use of chloroquine to treat multiple sclerosis
Rabinovitch et al. Interleukin 12 mRNA expression in islets correlates with β-cell destruction in NOD mice
Toyoda et al. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model
Ablamunits et al. Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-γ secretion pathway
CatAlfamo et al. Self-reactive cytotoxic gamma delta T lymphocytes in Graves' disease specifically recognize thyroid epithelial cells.
Abromson-Leeman et al. T cell responses to myelin basic protein in experimental autoimmune encephalomyelitis-resistant BALB/c mice
DE60130634T2 (en) IDENTIFICATION OF ANTIGENIC PEPTIDES BY CYTOTOXIC T-LYMPHOCYTIVES ACTIVATED BY DENDRITIC CELL HYBRIDS
JP3138481B2 (en) Use of IL-7 for the treatment of autoimmune diseases and especially insulin-dependent diabetes
AU712606B2 (en) Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
Saegusa et al. Autoantigen-specific CD4+ CD28low T cell subset prevents autoimmune exocrinopathy in murine Sjogren’s syndrome
Ito et al. Regulation of autoimmune diabetes by interleukin 3-dependent bone marrow-derived cells in NOD mice
Terres et al. The role of IL-4 and IL-10 cytokines in controlling an anti-tumor response in vivo.
US6022536A (en) Combined use of interleukin 10 and cyclosporin for immunosuppression therapy